Search filters

List of works by David Dalmau

A first update on mapping the human genetic architecture of COVID-19

scientific article published on 3 August 2022

A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppression.

scientific article published in July 2009

Added Value of Deep Sequencing Relative to Population Sequencing in Heavily Pre-Treated HIV-1-Infected Subjects ⬇️

scientific article published on May 13, 2011

Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

scientific article published on 24 September 2020

Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

scientific article published on 13 August 2012

Cognitive complaints in people with human immunodeficiency virus in Spain: prevalence and related variables ⬇️

scientific article published on June 4, 2013

Evaluation of Clinical and Immunological Markers for Predicting Virological Failure in a HIV/AIDS Treatment Cohort in Busia, Kenya ⬇️

scientific article published on November 21, 2012

Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 Study

scientific article published in October 2004

HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain

scientific article published in November 2009

Human genetic and immunological determinants of critical COVID-19 pneumonia

scientific article published on 28 January 2022

Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients

article

Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection

scientific article published in September 2003

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

scientific article published on 16 May 2022

Three-year follow-up of protease inhibitor-based regimen simplification in HIV-infected patients

article

Paulina is supported by:

About Paulina

Help